SUBSCRIBE
SUBSCRIBE

Opus Genetics

NEWS
Business
Spark Founders Launch Opus Genetics to Tackle Rare Forms of Blindness
The startup’s initial focus will be on rare blindness conditions affecting pediatric patients.
September 22, 2021
 · 
2 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Press Releases
Opus Genetics Added to the Russell 3000®, Russell 2000® and Russell Microcap® Indexes
June 26, 2026
 · 
4 min read
Press Releases
Opus Genetics Highlights Five Gene Therapy Programs Targeting Significant Unmet Need in Patients with Inherited Retinal Diseases
June 17, 2026
 · 
7 min read
Press Releases
Opus Genetics to Host Virtual R&D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts
June 2, 2026
 · 
2 min read
Press Releases
Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 28, 2026
May 29, 2026
 · 
1 min read
Press Releases
Opus Genetics to Present at the 2026 Jefferies Global Healthcare Conference
May 27, 2026
 · 
1 min read
Press Releases
Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference
May 13, 2026
 · 
1 min read
Press Releases
Opus Genetics Announces Financial Results for First Quarter 2026 and Provides Corporate Update
May 12, 2026
 · 
12 min read
Press Releases
Opus Genetics Presents Clinical and Preclinical Data at ARVO 2026 Demonstrating Continued Pipeline Advancement in Inherited Retinal Diseases
May 8, 2026
 · 
7 min read
Press Releases
Opus Genetics Completes Enrollment in Cohort 1 of Phase 1/2 OPGx-BEST1 Gene Therapy Study
May 7, 2026
 · 
5 min read
Press Releases
Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program
May 4, 2026
 · 
5 min read
Load More